Search Login Register
Laminin
(Merosin)
Summary
Description:
Large, noncollagenous glycoprotein with antigenic properties. It is localized in the basement membrane lamina lucida and functions to bind epithelial cells to the basement membrane. Evidence suggests that the protein plays a role in tumor invasion.
Also Known As:
Merosin; Glycoprotein GP-2; Laminin M; Laminin M Chain; Chain, Laminin M Show All >>
Networked: 3768
relevant articles (51 outcomes,
446 trials/studies)
for this Bio-Agent
Key Diseases for which Laminin is
Relevant
-
Neoplasms (Cancer)
:
6 outcomes 85 studies in 889 results
-
Fibrosis (Cirrhosis)
:
6 outcomes 12 studies in 162 results
-
Carcinoma (Carcinomatosis)
:
4 outcomes 42 studies in 289 results
-
Muscular Dystrophies (Muscular Dystrophy)
:
4 outcomes 22 studies in 274 results
-
Liver Cirrhosis (Hepatic Cirrhosis)
:
3 outcomes 4 studies in 70 results
Show All >>
Drugs Related to Laminin
-
Fibronectins (Fibronectin)
-
Hyaluronic Acid (Hyaluronan)
-
Collagen Type IV (Type IV Collagen)
-
Hydroxyproline (4 Hydroxyproline)
-
Collagen
-
Collagen Type III (Type III Collagen)
-
Transforming Growth Factor beta (TGF-beta)
-
Alanine Transaminase (SGPT)
-
Collagen Type I (Type I Collagen)
-
Messenger RNA (mRNA)
Show All >>
Therapies Related to Laminin
-
Transplants (Transplant)
-
Heterologous Transplantation (Xenotransplantation)
-
Drug Therapy (Chemotherapy)
-
Transplantation (Transplant Recipients)
-
Homologous Transplantation (Allograft)
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.